Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Legend Biotech Corporation - American Depositary Shares (NQ: LEGN ) 32.54 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 32.54 Bid (Size) 32.54 (11) Ask (Size) 32.58 (2) Prev. Close 32.54 Today's Range 32.54 - 32.54 52wk Range 32.08 - 70.13 Shares Outstanding 308,456,852 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Breaking Down Legend Biotech: 9 Analysts Share Their Views December 30, 2024 Via Benzinga Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference December 19, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Performance YTD N/A N/A 1 Month -24.87% -24.87% 3 Month -31.47% -31.47% 6 Month -27.27% -27.27% 1 Year -44.94% -44.94% More News Read More (LEGN) - Analyzing Legend Biotech's Short Interest December 16, 2024 Via Benzinga Deep Dive Into Legend Biotech Stock: Analyst Perspectives (10 Ratings) December 10, 2024 Via Benzinga Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights November 12, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Earnings Scheduled For November 12, 2024 November 12, 2024 Via Benzinga 9 Analysts Have This To Say About Legend Biotech October 16, 2024 Via Benzinga Where Legend Biotech Stands With Analysts September 27, 2024 Via Benzinga Peering Into Legend Biotech's Recent Short Interest September 06, 2024 Via Benzinga CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma December 09, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition November 07, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Beyond The Numbers: 14 Analysts Discuss Legend Biotech Stock August 28, 2024 Via Benzinga Looking Into Legend Biotech's Recent Short Interest August 16, 2024 Via Benzinga Beyond The Numbers: 15 Analysts Discuss Legend Biotech Stock August 12, 2024 Via Benzinga Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma November 05, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech Appoints Alan Bash as President of CARVYKTI® November 04, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results October 24, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia October 03, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients September 30, 2024 Via Benzinga CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line September 27, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma September 27, 2024 Via Investor's Business Daily Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 20, 2024 From Legend Biotech USA Inc. Via GlobeNewswire LEGN Stock Earnings: Legend Biotech Beats EPS, Beats Revenue for Q2 2024 August 09, 2024 Via InvestorPlace Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights August 09, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors August 08, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
